|
Baseline characteristics of patients (n = 50) |
|||
| Age (years) |
Median |
60 |
|
|
|
|||
| Range |
34–76 |
||
| Residual disease |
Absent |
17 |
(34%) |
| ≤ 1 cm |
6 |
(12%) |
|
| > 1 cm |
23 |
(46%) |
|
| Surgery not performed |
4 |
(8%) |
|
|
|
|||
| Stage |
IC |
3 |
(6%) |
| II |
6 |
(12%) |
|
| III |
29 |
(58%) |
|
| IV |
12 |
(24%) |
|
|
|
|||
| PS |
0 |
30 |
(60%) |
| 1 |
18 |
(36%) |
|
| 2 |
2 |
(4%) |
|
|
|
|||
| Grading |
1 |
2 |
(4%) |
| 2 |
14 |
(28%) |
|
| 3 |
22 |
(44%) |
|
| 4 |
12 |
(24%) |
|
|
|
|||
| Histologic type |
Serous |
30 |
(60%) |
| Mucinous |
3 |
(6%) |
|
| Endometrioid |
7 |
(14% |
|
| Undifferentiated |
3 |
(6%) |
|
| Clear cell |
1 |
(2%) |
|
| Mixed |
4 |
(8%) |
|
| Other |
2 |
(4%) |
|
|
PS = Performance Status | |||
Pignata et al. BMC Cancer 2006 6:202 doi:10.1186/1471-2407-6-202 |
|||